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Background: Non-adherence to prescribed treatments is the primary cause of treatment failure in pediatric long-term
conditions. Greater understanding of parents and caregivers’ reasons for non-adherence can help to address this
problem and improve outcomes for children with long-term conditions.
Methods: We carried out a systematic review and thematic synthesis of qualitative studies. Medline, Embase,
Cinahl and PsycInfo were searched for relevant studies published in English and German between 1996 and 2011.
Papers were included if they contained qualitative data, for example from interviews or focus groups, reporting the
views of parents and caregivers of children with a range of long-term conditions on their treatment adherence.
Papers were quality assessed and analysed using thematic synthesis.
Results: Nineteen papers were included reporting 17 studies with caregivers from 423 households in five countries.
Long-term conditions included; asthma, cystic fibrosis, HIV, diabetes and juvenile arthritis. Across all conditions caregivers
were making on-going attempts to balance competing concerns about the treatment (such as perceived effectiveness
or fear of side effects) with the condition itself (for instance perceived long-term threat to child). Although the barriers
to implementing treatment regimens varied across the different conditions (including complexity and time-consuming
nature of treatments, un-palatability and side-effects of medications), it was clear that caregivers worked hard to
overcome these day-to-day challenges and to deal with child resistance to treatments. Yet, carers reported that strict
treatment adherence, which is expected by health professionals, could threaten their priorities around preserving family
relationships and providing a ‘normal life’ for their child and any siblings.
Conclusions: Treatment adherence in long-term pediatric conditions is a complex issue which needs to be seen in the
context of caregivers balancing the everyday needs of the child within everyday family life. Health professionals may
be able to help caregivers respond positively to the challenge of treatment adherence for long-term conditions by
simplifying treatment regimens to minimise impact on family life and being aware of difficulties around child resistance
and supportive of strategies to attempt to overcome this. Caregivers would also welcome help with communicating
with children about treatment goals.
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Non-adherence is the primary cause of treatment failure
in pediatric long-term conditions [1]. Internationally, a
third to a half of all prescribed treatments are not adhered
to and the rates of non-adherence amongst children and
adolescents with long-term conditions is higher than
amongst adults [2].
‘Adherence’ is ‘the extent to which the patient’s behaviour
matches agreed recommendations from the prescriber’ [3].
We prefer it to the term ‘compliance’ because it includes,
but does not presume, the possibility of patient involvement
in the treatment decision making process. We do not
use the term ‘concordance’ because it assumes a shared
decision making process between patients and doctors [4].
Although shared decision making would ideally occur in
all clinical encounters, this cannot be assumed.
Quantitative research into barriers to treatment adher-
ence has identified a range of factors including: costs and
access to treatments; complexity and demands of treatment
regimen; lack of social support and depression [4]. Research
into promoting treatment adherence has found that the
most effective interventions are complex and include com-
binations of more convenient care, information, reminders,
specific behavioural change techniques [3-5] and involving
patients in the decision-making process [6]. Adherence
interventions amongst pediatric populations also show
that multicomponent interventions are most effective.
[7,8] However, the effect sizes are inconsistent across
studies and settings [9], effect sizes are small and more
research is needed [10].
There is a recognised need for qualitative research to
understand the complex behaviour of treatment adherence
[3]. A systematic review and synthesis of qualitative papers
on treatment adherence that focussed primarily on adults
[11] found a reluctance to take medicines in general; a
preference to take as little as possible; a widespread
practice of personal testing of medicines, mainly for adverse
effects; and patients modifying treatment regimens to make
them more acceptable.
Treatment adherence in pediatric care has been less
extensively studied [12], yet influences appear even more
complex than in the care of adults. For example, the
burden of treatment generally lies with caregivers rather
than with the patients themselves. Additionally, whereas
in adults the therapeutic relationship is between the
medical team and the patient, in pediatric care there is a
‘therapeutic triad’ with communicative interactions between
parent -professionals; child - professionals and parent -
child [6].
Qualitative research is one way of better understanding
the views of patients and caregivers. Whereas quantitative
research and clinical trials provide strong evidence about
mechanisms of adherence and effectiveness of interven-
tions, qualitative research exploring caregivers’ experiencesof treatment adherence might offer additional insights.
These could inform the development of new interventions
or enhance the understanding of clinicians who communi-
cate with families regarding treatment adherence in their
everyday practice. There has been no review of the qualita-
tive literature focusing on treatment adherence in pediatrics
even although there are a number of such studies which
could be synthesised. We therefore conducted a systematic
review and synthesis of the qualitative literature to investi-
gate parents and caregivers’ accounts of their reasons for
adherence and non-adherence to prescribed treatments in
pediatric long-term medical conditions.
Methods
The synthesis of qualitative research is an emerging field
and several approaches exist [13]. We used the principles
of thematic synthesis, an established approach previously
used in public health [14].
Selection criteria
Papers included in our study had to report qualitative
findings, for example from interviews and focus groups,
providing insight and meaning into treatment adherence
or non-adherence from the perspective of parents and
other caregivers (but not health professionals) of children
with long-term conditions. (This topic did not need to be
the primary focus of the original research studies). As our
focus was on caregiver adherence, included studies had
report on data from caregivers of children aged 12 or
younger (studies solely reporting the views of caregivers
of teenagers were excluded).
Our focus was on clinical conditions that would widely
be viewed as ‘long-term illnesses’. We therefore included
conditions such as asthma and diabetes but excluded
behavioural, developmental and/or mental health condi-
tions (such as autism) as well as visual and hearing impair-
ments. Papers relating to adherence to treatments for the
prevention of rejection following organ transplant were
also excluded as these formed a substantial number of
papers and would have led to an excessive number and
heterogeneity of papers. We included studies where
caregivers were given specific treatment advice and in-
structions but excluded studies where general advice
was given. So studies reporting on parents delivering
physiotherapy in juvenile chronic arthritis were included
but not studies where parents were encouraging children
with asthma to be more physically active. Thematic synthe-
sis necessitates having a depth of data which can be
brought together. Included papers therefore had to pro-
vide a substantial amount of data on treatment adherence
or non-adherence (not just brief descriptions of these
within the wider context of coping with chronic illness
generally). As such, at least half the findings presented in
included studies had to focus specifically on treatment
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papers which solely reported treatment adherence in devel-
oping countries, as the barriers to treatment adherence
would differ substantially in this context. To avoid misinter-
preting reported findings, included papers were in English
or German – languages spoken by the researchers.
Literature search
Four electronic databases were searched in December 2011
(Medline, Embase, Cinahl and PsycInfo) with search strat-
egies that used both Medical Subject Headings terms and
text words (see Table 1). Although there are differences in
terms of meaning between adherence, concordance and
compliance, all three terms were searched for to increase
the sensitivity of our searches. Databases were searched
from the last 15 years, as qualitative research is not well
indexed prior to this date and this reflects the date of the
earliest papers on this topic that we are aware of [15].
Additional papers were sought by writing to authors and
examining reference lists of included papers. Titles and
abstracts were initially screened and if these indicated that
the paper might meet the inclusion criteria, the full text
paper was retrieved and examined against our inclusion
criteria. Where there was any uncertainty about inclusion,
for instance if a paper provided data on treatment
adherence by caregivers but of insufficient depth for
synthesis, this was discussed within the research team.
Further details of literature search and screening are
shown in Figure 1.
Quality of reporting
Papers meeting our inclusion criteria were quality assessed
using an adapted version of the CASP quality assessment
tool [17] (see Table 2). We used quality appraisal primarily
to enable a critical review of each paper and to assess
transparency of reporting of methods, but not as a means
of excluding papers, given the debate over essential criteria
for reporting qualitative studies [18]. Assessing potentialTable 1 Sample search strategy
Medlin
1996 to
1 Patient compliance/or patient compliance.mp
[mp=title, abstract, cas registry/ec number word,
mesh subject heading
29
2 Adherence.mp 48
3 Qualitative$.mp 80
4 1 or 2 70
5 5 and 6 1
6 Limit 5 – all child (0 to 18 years) 3
Notes:
Multiple searches of the electronic databases were carried out – this is just one exa
Searches such as the one above were then carried out in combination with commo
and juvenile arthritis, sickle cell anaemia, bowel disease.papers against inclusion criteria and assessing quality
was completed independently by two researchers (MS, NR,
SW and AG) working independently and then collaborating
to compare findings. Any differences were resolved through
discussion.
Data extraction and analysis
Thomas and Harden [14] describe three stages in thematic
synthesis: coding text; developing descriptive themes and
generating analytical themes. Data were extracted from
included papers in two phases. In phase 1, details about
study design and participants were extracted onto a pre-
viously adapted template [19]. In phase 2, the findings
and discussion from included papers relating to treat-
ment adherence (or non-adherence) by caregivers were
imported into Nvivo9 software. In order to develop de-
scriptive themes, three reviewers independently coded
this text in 10 original papers – these were chosen as
they covered different conditions and provided a breadth
of findings – to identify provisional themes according to
meaning and content (MS, NR and SW). These three re-
viewers then discussed their independently derived
themes and agreed a preliminary coding frame of main
themes. This coding frame was then applied to data in
all papers. Data were coded independently by two re-
viewers with any differences between coders resolved
through discussion and the coding frame refined where
necessary.
Once all papers were coded and data presented as
descriptive themes, we needed to ‘go beyond’ the original
author interpretations of their data to provide analytical
themes. This was an iterative and inductive process in
which we explored relationships between the different
papers and long-term conditions to create new insight
and meaning. This process involved extensive team
discussion and reflection to refine descriptive themes
and develop over-arching analytical themes derived from
all included studies.e (Ovid) Embase (Ovid) Cinahl PsycInfo
Dec 2011 1996 to Dec 2011
572 67481 10966 687
282 59237 2057 3897
103 97242 35739 60138
065 112359 3901
672 2132 494 208
31 152 86 24
mple. Other search strategies included using ‘concordance’ as a key word.
n long-term conditions in children, such as asthma, diabetes, cystic fibrosis
506 abstracts screened against study
inclusion criteria
51 full text articles assessed for eligibility
455 abstracts excluded for not meeting study criteria:
Developmental / behavioural conditions (e.g.
ADHD)
Developing countries only
Not in English or German
Not qualitative
Full text papers excluded:
2 review papers
3 not qualitative full text had been obtained
because abstract suggested paper might contain
qualitative data
26 less than 50% of findings relating to adherence
1 no pre-teenage children
based on PRISMA reporting flowchart [36]
10 records identified through contacting authors 
33 records identified through examining references
506 records after duplicates removed
19 papers  (17 studies) were included in
thematic synthesis
583 records identified through searches of
4 electronic databases
Figure 1 Literature searching & screening flowchart. Based on PRISMA reporting flowchart [16].
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506 possible studies were assessed against our inclusion cri-
teria with 17 studies (19 papers) finally identified as meet-
ing our study inclusion criteria. These papers presented
rich data from qualitative studies reporting caregivers viewsTable 2 Quality Appraisal Criteria and Outcome of Quality As
Quality assessment criteria*
1 Is this study qualitative research?
2 Are the research questions clearly stated?
3 Is the qualitative approach clearly justified?
4 Is the approach appropriate for the research question(s) asked?
5 Is the study context clearly described?
6 Is the role of the researcher clearly described?
7 Is there a clear connection to an existing body of knowledge/wider
theoretical framework?
8 Is the sampling method clearly described?
9 Is the sampling strategy appropriate for the research question(s)?
10 Is the method of data collection clearly described?
11 Is the data collection method appropriate to the research questions
12 Is the method of data analysis clearly described?
13 Is the data analysis method appropriate to the research question(s)?
14 Are the claims made supported by sufficient evidence?
Notes:
*Questions 1–14 incorporate the 13 criteria used by Atkins et al. [17] which is, in tu
†Quality was assessed based on what was written in the papers. The limited word c
information, particularly on methods, so what is written in a paper may not reflecton treatment adherence or non-adherence in a range of
pediatric long-term conditions (predominantly asthma,
juvenile rheumatoid arthritis, cystic fibrosis, HIV, diabetes)
from 423 households in five countries published over an
15 year period (1996–2011) (Table 3). Caregivers includedsessment of the 19 included papers
Number meeting
criteria in full† (%)
Number meeting
criteria in part (%)
Number not
clear (%)
18 (95%) 1 (5%) 0
16 (84%) 1 (5%) 2 (11%)
13 (68%) 4 (21%) 2 (11%)
16 (84%) 3 (16%) 0
8 (42%) 9 (47%) 2 (11%)
3 (16%) 10 (53%) 6 (32%)
14 (74%) 3 (16%) 2 (11%)
12 (63%) 5 (26%) 2 (11%)
11 (58%) 7 (37%) 1 (5%)
17 (89%) 2 (11%) 0
? 16 (84%) 3 (16%) 0
14 (74%) 2 (11%) 3 (16%)
6 (32%) 10 (53%) 3 (16%)
4 (21%) 13 (68%) 2 (11%)
rn, adapted from the Critical Appraisal Skills Programme (CASP).
ount for journal publication may mean that authors of qualitative studies omit
the quality of the research study.
Table 3 Summary information on included papers
Ref Source paper Condition Country and setting Participants Data collection
[15] Knafl et al. 1996 Various long-term
conditions
US: Recruited from 3 health
centres
63 families of children age 7–14 yrs
(36 diabetes, 7 renal disease, 7 asthma,
6 arthritis, 9 other)
Interviews
[20] Bokhour et al. 2008 Asthma US: Diverse health care settings 37 parents of 37 children age 5–12 yrs Home interviews
[21] Peterson-Sweeney
et al. 2003
Asthma US: Setting unclear 18 mothers of children age 2–18 yrs Home interviews
[22] Callery et al. 2003 Asthma UK: Emergency room & primary
care
Main caregivers of 25 young people
age 9–16 yrs
Home interviews
[23] Foster et al. 2001 Cystic fibrosis UK: Single hospital clinic 8 mothers, 1 father of children age
10–18 yrs (8 households)
Interviews
[24] Slatter et al. 2004 Cystic fibrosis UK: Database of children with
cystic fibrosis
17 interviews with parents of children
age 3–12 years (15 households)
Home interviews
[25] Williams et al. 2007a Cystic fibrosis UK: 2 hospital clinics 31 parents of 32 children age 7–17 yrs Home interviews
[26] Williams et al. 2007b Cystic fibrosis As above As above As above
[27] Hammami et al. 2004 HIV Belgium: Single hospital clinic 11 caregivers of children age 0–18 yrs Interviews
[28] Merzel et al. 2008 HIV US: Treatment adherence project 14 caregivers of 15 children age
10–16 yrs
Interviews
[29] Wrubel et al. 2005 HIV US: Participants from research study 71 maternal caregivers (biological,
foster, adoptive mothers or other
female relatives) of children age 1–18 yrs
Hospital or home
interview
[30] Britton & Moore 2002 Juvenile arthritis UK: Single hospital clinic 9 families of girls age 7–8 or 11–13 yrs Home interviews
[31] Sullivan-Bolyai et al.
2003a
Diabetes US: 2 hospital clinics 28 mothers of children aged 0–4 yrs Home interviews
[32] Schilling et al. 2006 Diabetes US: Participants from research
studies
17 mothers and 5 fathers of 22 young
people age 8–19 yrs
Home interviews
[33] Schroder et al. 2002 Juvenile arthritis Australia: Single hospital clinic 5 mothers of children age 3–10 yrs Interviews
[34] Prout et al. 1999 Asthma UK: 2 primary care centres 9 families of children age 7–12 yrs Varied data
collection
[35] Klok et al. 2011 Asthma Netherlands: single hospital clinic
and primary care
44 parents of children age 2–12
(34 households)
Focus groups
[36] van Dellen et al. 2008 Asthma Netherlands: Multicentre research 28 mothers of children age 7–17 yrs Focus groups
[37] Sullivan-Bolyai
et al. 2003b
Diabetes As above As above As above
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relatives.
Findings
Overall, findings regarding caregiver treatment adherence
and non-adherence were similar across conditions yet, as
the impact on daily life from both the treatment and the
condition varied widely, there were some notable dif-
ferences between conditions. Findings that contribute
to explaining treatment adherence can be summarised
according to six main themes: (1) beliefs and about the
condition or the treatment (2) difficulty of treatment
regimen; (3) child resistance; (4) relationships within
families; (5) preserving ‘normal life’; and (6) input from
health professionals. Each theme is briefly described below
with additional details provided in Table 4 and Table 5.
We then present our analytical overview; balancing com-
peting priorities around treatment adherence needs to beviewed in the broadest context, including preserving fam-
ily relationships and promoting ‘normal life’ for the child.
Caregiver beliefs about long-term conditions and treatments
This was the most commonly reported theme (noted across
all 19 papers) and it had a major impact on caregiver deci-
sions regarding treatment adherence and non-adherence.
This theme consisted of two sub-themes: caregiver beliefs,
concerns or fears about the condition (such as its perceived
long-term threat to the child) and caregiver beliefs about
the treatment (including perceived effectiveness or fear of
side effects).
Thirteen papers described how caregivers attempted to
weigh up beliefs about the child’s long-term condition
against positive or negative beliefs about the treatment
and other barriers to treatment (Table 5). For instance, in
asthma, fears about potential side effects from inhaled ste-
roids were weighed against fears of acute exacerbations
Table 4 Example data excerpts for each theme
Theme Example data excerpts
1a. Beliefs about the condition (assessment of symptoms,
degree of long-term threat; predictability of condition
and explanatory models)
Whenever he starts to come down with a cold. You know, if he has the sniffles, then
I will start him. I will say okay, you should definitely be on your medication. . . . When
I think that he is well enough to be taken off of the medication then I do. asthma [20]
I do get worried about it yes. I feel very guilty, and I know, you know, we’re going to lose
her, I shall lay at night thinking of all the times we didn’t do it and didn’t nag her to do it,
and she’d be here now if, em, you know we had been rigid with her. cystic fibrosis [23]
1b. Beliefs about the treatment (efficacy, side effects) I just think you hear so many things about steroids. When he was four months, he was
given Prednisone, his teeth were coming out. … They got ruined . . . Some kids who
get a lot of steroids, studies show that they have got hip replacements. Something that
eats your bones or something. Asthma [20]
I realize that I have the power to postpone the death of my child thanks to the
medication. HIV [25]
2. Difficulty of treatment regimen It's overwhelming. It affects everything you do even though you don't want it to. You
don't want it to control your life but it does. Diabetes [15]
As you can appreciate, if you’re putting them on at night … when she’s screaming that she
can’t stand to have them on anymore too, it’s very difficult. splinting for juvenile arthritis [33]
3. Child resistance She’s having a difficult time right now and I’m having a difficult time. She absolutely
refuses to write down her blood sugars. I had taken the attitude that I wasn’t going
to push and make her follow all these guidelines exactly. I don’t know if that is so
good right now. It’s very difficult. Diabetes [15]
Cause when she was small, giving her the medication didn’t have too much of a
problem. She would take it. But now making sure she takes it, watching over her,
standing behind, it’s really rough ‘cause she forgets. I have to be the one to remind
her… sometimes she gets so careless… and I have to get rough at her, you know,
about taking the medication. HIV [28]
You end up battling with your child and getting nowhere. juvenile arthritis [30]
4. Impact on relationships within families I felt almost cruel sometimes making her do it but I have to. juvenile arthritis [30]
Often he says, “If you give it to me I’ll throw up.” So that night he went to bed and I
didn’t give him his medication. I gave it to him the next morning and that was it.
Sometimes when he’s really, really upset I don’t say anything. I just let it go. HIV [29]
I think if you didn’t differ and you didn’t give a bit and take a bit, the children would
go mentally deranged, they would, but if you were the sort of parent, and I’m sure
there are, that say, right it’s 9.02 and have you had your this and have you had your
that? It would crucify a child I think, I really do. cystic fibrosis [24]
5. Preserving ‘normal life’ I don’t say that much to him [about asthma]. Because I mean you have to be careful else
(sic), well you can’t make them. But I try not to say much to him, you know. Because he has
got to get on with his life. You know we try to let him do as much as he can and do what
he can. He has got to get on with that side of his life. I mean I could make him paranoid
but I think that’s why he is OK about taking his medicine. Asthma [34]
If you’re just saying look the only thing that’s important is medication, X would say
no it isn’t I want to go and have a life. cystic fibrosis [24]
He was telling Dr A ‘I don’t like taking my medicine in school because the kids, they
nosy and they bother me.’ So Dr A told me, she said well, why don’t you take your
medicine at three o’clock when you come out of school, when you get home. HIV [28]
6. Input from health professionals I didn’t actually think we were told how important the exercises were. I don’t even
remember somebody saying anything. I know the importance now but if somebody
had just sat down and said if only you knew how good these were, drummed it into
us but they weren’t. I can remember her going to [named hospital for outpatient
physiotherapy] … and she walked out of there and I thought brilliant but they never
sat me down and said you’ve got to do this. juvenile arthritis [30]
As far as this med stuff goes, having the kids making decisions, it just doesn’t work.
They can’t. They’re not old enough. Their brains aren’t mature enough [laughs]. And
they’re just teenagers. Teenagers can’t even make decisions about school. Easy things.
My daughter and I had talked about it. And actually she doesn’t want to have to be
concerned with what’s going on. That’s always been my job. And she’s not ready to
have to make the decisions. She doesn’t know how to. And she’s tried to tell them
that, and they’re not listening. (Adoptive mother of a 15-year-old girl) HIV [29]
But once they talked to her and let her really know the importance of its, and that it’s
for her good, she’s doing much better. HIV [28]
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Table 5 Themes arising from included papers
Themes Asthma papers Cystic fibrosis
papers
HIV
papers
Diabetes
papers
Juvenile arthritis
papers
Mixed long-term
conditions
Reference 19 20 21 33 34 35 22 23 24 25 26 27 28 30 31 37 29 32 15
Competing beliefs and concerns
regarding treatment and the
condition itself
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Difficulty, unpalatability or
complexity of treatment
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Child resistance ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Preserving family relationships ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Preserving normality or prioritising
a ‘normal life’ for the child
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Input from health professionals ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
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holding regular medication to observe whether their
child still needed them [22].
All the studies of families with children with cystic fibro-
sis described the tension caregivers experienced between
having to overcome the many barriers to treatment adher-
ence (especially time-consuming therapy and child resist-
ance) against their strong belief that adherence to, at least
some of, the prescribed treatments would keep their child
healthy for longer [23-26]. One author described caregivers
as ‘being caught between the illness, the child and the ther-
apy’ [26]. Caregivers knew, for example, that cystic fibrosis
meant their child would die prematurely but that chest
physiotherapy might delay this, yet they also saw how much
their child disliked and resented such treatment [26].
Difficulty of treatment regimen
Barriers to adherence relating to specific treatment regi-
mens was identified as a theme in approximately half of
the included papers (Table 5). Caregiver reported difficulties
included time-consuming or complex treatment regimens
(such as chest physiotherapy for cystic fibrosis) [23-26]
or unpalatable treatments or those with side effects
(particularly HAART (highly active antiretroviral therapy)
for HIV) [27-29] or painful treatments (physiotherapy for
juvenile arthritis [30]).
Many papers reported caregivers’ descriptions of practical
strategies and routines they had developed to cope with the
difficulty of the treatment regimen. Some caregivers spoke
positively about establishing a routine and how this
could help with remembering treatments. Routines were
also considered beneficial in fitting treatment regimens
into family life and could help avoid child resistance devel-
oping as children came to expect their treatment as part
of ‘normal’ routine.
Conversely, some caregivers perceived the rigidity of a
routine as problematic, for example in children with dia-
betes, where caregivers described the ‘constant vigilance’
following initial diagnosis and adherence to a rigid routinegradually developed into ‘flexible adherence’ as caregivers
gained confidence and were more able to adapt treatment
regimens to ‘normal life’ [31]. Furthermore, some studies
in cystic fibrosis [26] and HIV [28] found that caregivers
believed a more flexible approach to adherence could
promote the emotional well-being of the family and,
therefore, the affected child.
Child resistance
Conflicts with children over treatment adherence were
widely reported by caregivers, across all conditions, as
a barrier to adherence and a source of stress (Table 4
and Table 5). Some caregivers described a pattern of
repetitive resistance, where the child fiercely refused
most treatments leading to daily ‘battles’ and caregiver
fatigue. This was particularly problematic where the
treatment was aversive (unpalatable or caused adverse
side-effects) or time-consuming (physiotherapy for cystic
fibrosis or juvenile arthritis) as children resented the bore-
dom of these activities.
Caregivers were not only concerned about the impact
of child resistance on adherence and treatment of their
condition, but they also faced dilemmas about how best
to deal with it. Some caregivers were less able or willing to
cope with the distress of, or dissent from, the child and
these families tended to discontinue the treatment [30].
The child’s age and development influenced how care-
givers viewed their responsibility for treatment adherence,
their experience of child resistance and how to deal with
it. A further tension was identified in diabetes and asthma,
with caregivers wishing to encourage the child’s inde-
pendence in managing their own care while also wishing
to ensure that treatment adherence was as good as possible
through parental involvement [21,32].
Impact on relationships within families
Perceived threats and strains to family relationships was a
recurring theme relating to treatment adherence particu-
larly in papers on cystic fibrosis, HIV and juvenile arthritis
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through (i) a child’s repetitive resistance to treatment lead-
ing to conflict, (ii) difficulties with handing responsibility
for treatment over to older children, (iii) the child holding
a different view of the treatment or condition than the
parent or parents holding differing views from each other.
For example, Williams et al. [26] highlighted that children
may take a different view of cystic fibrosis treatment from
their caregivers associating treatment with illness and
infection, rather than with health and well-being [26].
Conflict between caregivers and children over treatments
were sometimes directly described as resulting in non-
adherence, as illustrated in Table 4 by the quote from a
caregiver of a child with HIV.
Preserving ‘normal life’
Across all the long-term conditions, authors identified
how promoting ‘normal life’ for the child with a long-term
condition was a parental/caregiver priority yet treatment
adherence challenged this goal, particularly where treat-
ments were time-consuming or where child resistance
developed (Table 5). Time-consuming therapies, such as
physiotherapy for juvenile arthritis or cystic fibrosis, pre-
sented a difficulty as this was time spent to the exclusion
of other family members and other activities; some care-
givers felt that the regimen had to be contained so that it
did not impinge on ‘normal’ activities [26].
Highly visible therapies, such as wearing splints for
juvenile arthritis [33], were also viewed as threats to
‘normal life’ by drawing attention to the child’s condition.
This was particularly problematic for caregivers of children
with HIV, who reported difficulties giving treatment to
children in front of others who were unaware of their
child’s HIV status, due to the perceived stigma of the
condition [27]. Conversely, in asthma, there was evidence
that inhalers were viewed as facilitating normality as they
allowed children to join in activities which would otherwise
have been difficult for them [34]. In diabetes, treatment
was also viewed as facilitating normal life in that it kept
the child well [31].
Input from health professionals
Input from health professionals was mentioned by care-
givers across all conditions as influencing their beliefs
about the illness and the treatment. Health professionals
were seen as a source of advice on how to overcome diffi-
culties with the treatment regimen; or to help communicate
with their child about treatment goals.
Where treatments were not observed to be immediately
beneficial, a strong relationship between caregivers and
health professionals appeared to have an important role in
promoting treatments [25,35]. Findings from HIV studies
reflected that the caregivers viewed healthcare profes-
sionals as a source of support in overcoming challengesto adherence, for instance for advice about dealing with
un-palatability and gastro-intestinal side-effects [28,29].
Some caregivers felt that they were unable to get the
child to fully adhere to the regimen and needed the help
of health professionals, who were better able to encourage
the child to implement their treatment [25,28].
Although input from health professionals was generally
seen in a positive way, there were some cases where care-
givers and health professionals did not share the same per-
spectives. For example, one study reported that caregivers
felt medical staff tried to engage with their child before that
child was ready to be involved in treatment decisions [29].
Also, some caregivers did not always hold the same views
as their health professionals regarding a condition. For in-
stance, caregivers did not always see asthma as long-term
condition requiring constant preventative treatment or
they did not perceive inhaled steroids to be a safe treat-
ment [35,36].
Analytical overview
Drawing together the themes from all included studies
allowed us to gain an overview of the full range of factors
that influence caregivers in their everyday management of
treatment adherence for long term pediatric conditions.
While individual authors have highlighted concerns of
parents regarding balancing competing concerns about the
treatment and the condition, or between child resistance
and strict adherence, this overview demonstrates that this
balance needs to be viewed in the widest context, including
preserving family relationships and promoting ‘normal life’
for the family. Caregivers may have been implicit or explicit
in their descriptions of how they attempted to reconcile
their competing concerns or priorities but all experienced
tensions and this complex juggling of the needs of the child
and the family reflects the juggling act that caregivers carry
out in everyday life.
Discussion
This study thematically synthesised 19 papers from 17
studies in 5 countries reporting on how caregivers manage
treatments in a range of long-term conditions. Our findings
reveal that a wide range of factors contributed to treatment
adherence (or non-adherence) in these pediatric long-term
conditions. The papers we synthesised were diverse in
terms of long-term conditions, types of caregivers and
the age range of children cared for but one over-arching
theme arising from all these studies was that caregivers
sought to balance many competing concerns about the
condition and its treatment in the context of everyday
family life. Their ability to adhere to a treatment regimen
depended on several key factors – difficulty associated
with its implementation (such as treatment side-effects)
and child resistance and the threat that these factors posed
to family relationships and ‘normal life’ for the child and
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on-going for caregivers of children with long-term con-
ditions and they worked hard to overcome challenges
on a day-to-day basis. Health professionals have a key role
in supporting treatment adherence in pediatric long-term
conditions.
A strength of this review is that through drawing to-
gether qualitative findings on diverse pediatric long-
term conditions, we were able to see patterns that may
not otherwise have emerged and identify the full range
of factors influencing treatment adherence and the
needs of caregivers in relation to prescribed treatment
regimens. Many of our findings support those of the
meta-ethnography of qualitative research on treatment
adherence in adults [11]. For example, both reviews found
that people modify treatment regimens to make them
more acceptable and to ‘fit’ with everyday life.
Our findings provide empirical support for the concept
of a ‘therapeutic triad’ in pediatric adherence [6] with par-
ticipants in these studies citing both their child and health
professionals as important in influencing their adherence
practices. Such findings can inform everyday consultations
in pediatric long-term conditions. The additional com-
plexity in the pediatric encounter of the ‘therapeutic triad’
rather than a ‘therapeutic dyad’ represents a challenge to
health professionals to develop sophisticated communica-
tion strategies. For instance, health professionals may be
able to assist parents and caregivers by helping the child
view their treatment as enabling health and a ‘normal life’,
rather than representing illness and interference [26].
Participants in these studies wished for more support
from health professionals in devising simpler treatment
regimens that take account of family life, seeking solutions
to barriers to adherence and communicating with their
child about adherence. Providing opportunities to discuss
barriers to adherence before repetitive resistance develops
could be a great help to caregivers.
A limitation of our review is that the participants in-
cluded in these studies may not have been fully repre-
sentative of less adherent families in some cases. A further
limitation is that we considered only papers which included
data from caregivers – we did not include papers reporting
children’s views about treatment adherence. Our need
to include studies with children of varying ages meant
we excluded papers on other long-term conditions such
as sickle cell anaemia and inflammatory bowel disease
which focused on teenagers only. A synthesis of qualitative
studies focusing on the views of children and young
people with long-term conditions would be therefore
valuable in future.
Conclusions
In practice, treatment adherence by caregivers is the
result of a complex balancing act of competing concernsincluding their beliefs about a condition and its treatment,
managing child resistance, preserving family relationships
and promoting ‘normal life’ for the family. Health profes-
sionals need to understand the complexities surrounding
treatment adherence and non-adherence in order to
support caregivers in developing treatment regimens that
minimise impact on everyday life and family relationships.
This means simplifying regimens and being prepared to
discuss strategies to address or pre-empt child resistance,
including communicating treatment goals to the child so
far as possible.
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